Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model

The role of HBsAg quantification for monitoring natural history and treatment outcome

(2013) Michelle Martinot-Peignoux et al.   LIVER INTERNATIONAL

DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model

(2012) A. D. Kosinska et al.   JOURNAL OF VIROLOGY

Clinical implications of HBsAg quantification in patients with chronic hepatitis B

(2012) Pietro Lampertico et al.   Saudi Journal of Gastroenterology

Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: A multicenter clinical experience

(2011) Dilip Ratnam et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Vaccination Against Hepatitis B and C: Towards Therapeutic Application

(2009) Geneviève Inchauspé et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Immune effectors required for hepatitis B virus clearance

(2009) P. L. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regulatory T Cells Suppress Antiviral Immune Responses and Increase Viral Loads during Acute Infection with a Lymphotropic Retrovirus

(2009) Gennadiy Zelinskyy et al.   PLoS Pathogens

Antiviral therapy with entecavir combined with post-exposure “prime-boost” vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection

(2008) D.S. Miller et al.   VIROLOGY